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1INTRODUCTION
Bladder cancer is one of the commonest malignancies and worldwide it is the
fourth most common malignancy in males and eighth in females1. About 70% of
patients with Bladder cancer have disease limited to the mucosa or sub-mucosa.
This group forms the main bulk of the disease and is termed as non-muscle
invasive or superficial bladder cancer2. The success of therapy in non–muscle-
invasive bladder cancer (NMIBC) relies upon the biologic nature of the tumour
and on the treatment chosen. Endoscopic surgery is considered the main
treatment of non–muscle invasive tumours (Ta and T1)3.
In 1910, Edwin Beer, changed the paradigm of  managing bladder tumours from
Open surgery to Endoscopic management4. In 1931, the first cutting loop
resectoscope was introduced by Stern and McCarthy which gave a boost for
transurethral surgeries. Several modifications in technology and technique have
evolved, but loop resection remains the gold standard5.
 Endoscopic resection of the growth (TURBT) is the most important and a
crucial step in the management of non–muscle-invasive tumours. The objective
of  TURBT is to (1) Know the histology of the tumour (2) Stage the tumour (3)
Grade the tumour and 4) possibly achieve cure6.
2The most common energy source used in TURBT is conventional Monopolar
electrosurgery.  But Monopolar electrosurgery has its own drawbacks. First, the
patient’s body forms a part of the electrical circuit. Second, for irrigation non-
conducting solutions like Sterile water, Glycine are used, which increases the
incidence of  TUR syndrome. Third, the incidence of obturator jerk is more with
Monopolar  TURBT.  So, in order to overcome these drawbacks there has been
lots of advances in the surgical technique and technology. One of the
improvements in technology is Bipolar energy source, which is well proven for
its efficacy and is in common use for TURP (Transurethral resection of
prostate)7.
The quoted reason for the benefit of Bipolar over Monopolar is decreased
incidence transurethral resection syndrome (TUR syndrome) as it uses saline for
irrigation which is proven beyond doubt in TURP. But the incidence of
transurethral resection syndrome is as such rare in bladder tumour resection
even with Monopolar electrosurgery. This may be the reason for non-popularity
of  Bipolar TURBT8.
There are only few studies in published literature comparing the Monopolar and
Bipolar resection of bladder tumours. This study aims to elucidate the safety
and efficacy of Bipolar TURBT in comparison to Monopolar transurethral
resection (TURBT) in bladder tumours.
3AIM AND OBJECTIVE
The primary aim and objective of the present study is to evaluate the
Safety and efficacy of  Bipolar energy in resecting bladder tumors and with a
secondary objective to study the histological changes (Thermal artefacts) noted
in the resected specimens between the Monopolar and Bipolar energy.
4REVIEW OF LITERATURE
The Bladder
Bladder functions as a reservoir and varies in size, morphology, position and
relations as per its content and the nature of surrounding viscera. It lies entirely
in the pelvis when empty and extends antero-superiorly into the peritoneal
cavity when full. It is approximately tetrahedral in shape when empty and has
two inferolateral surfaces, superior surface, base and neck9.
The base or the Trigone is triangular and lies postero-inferiorly. The base is
closely related to the anterior vaginal wall in females and to the rectum in
males. The Seminal Vesicle and Vas deferens lie on each side in close
approximation to the bladder. The fascia separating the bladder and rectum is
referred to as the Rectovesical fascia, which is also known as Denonvillier's
fascia10.
The Neck of the bladder is the lowest and the most fixed part. It lies about 3-4
cm posterior to the symphysis pubis. The bladder neck changes little in position
with bladder filling. In males, the bladder neck lies in close proximity to the
base of the prostate9, 10.
5Bladder Mucosa11
The bladder mucosa is loosely attached to the underlying muscle in most parts
of the bladder except Trigone where it is firmly adherent. Thus when the
bladder is empty mucosa is thrown into folds and the folds disappear when
bladder gets filled. But in Trigone the mucosa changes little with filling and
emptying of the bladder.
Trigone of the bladder is bound by three anatomical land marks, namely, the
Ureteric orifices and the internal urethral meatus. The interureteric region is
thickened due to the continuation of inner longitudinal muscle from the ureters
and is called the Inter-ureteric crest or Mercier’s bar. During cystoscopy the
Mercier’s bar appears pale and is an important landmark in tracing the Ureteric
orifices as they are located at its extremity.
Bladder mucosa is made up of specialised cells called the Transitional cells,
which are 5-7 layers thick all around except at the trigone where it is only 3
layers thick. This is also called as the Urothelium.  Subjacent to the urothelium
lies the lamina propria which contains the blood vessels and lymphatics. The
Lamina propria contains a discrete layer of discontinuous smooth muscle layer
called the muscularis mucosae, which has a significance in that it creates
confusion in histopathological sections and sometimes while staging the tumour
this can be confused for detrusor and staged as muscle invasive.
6Detrusor9, 11
The smooth muscle of the bladder is called as the Detrusor and is indistinctly
arranged into three layers namely inner and outer longitudinal and middle
circular. But near the Trigone and bladder neck the three layers are clearly
appreciable. The inner longitudinal layer is continuous with inner smooth
muscle of urethra. The middle circular layer forms the pre-prostatic sphincter
and the outer posterior layer is thickest and provides backing for Trigone.
The muscular layer of the Trigone has three distinct layers: (1) a Superficial
layer which is continuation of the longitudinal muscle of the Ureter (2) a Deep
layer, from the Waldeyer sheath and (3) a Detrusor layer proper
URETERIC ORIFICES AND URETERO-VESICAL JUNCTION12
The Ureteric orifices are slit-like apertures, present at the extremities of inter-
ureteric crest. They are 2.5 cm apart in empty bladder and 2.5 cm from internal
urethral meatus and when bladder gets full these dimensions double. The
uretero-vesical junction forms an important part of the urinary tract in that it not
only allows antegrade flow of urine, but also prevents retrograde flow of urine
from the bladder thereby preventing refux and its effect on the kidneys. The
importance of this is that in the presence of reflux there is high likelyhood of
seedling of urothelial tumours from the lower tract.
7BLOOD SUPPLY AND LYMPHATIC DRAINAGE9
ARTERIES
The main arterial supply to the bladder is derived from the superior and inferior
vesical arteries, which in turn are branches of the anterior division of the
internal iliac artery. Additional supply is provided by the obturator and inferior
gluteal arteries in both sexes and few branches from the uterine and vaginal
arteries in females.
VEINS
The veins from the bladder form a plexus near the inferolateral surfaces and
finally empty into the internal iliac veins.
LYMPHATIC DRAINAGE
Lymphatics from the bladder mainly drain into the external iliac nodes. Also
lymphatics from the Trigone and inferolateral wall drain additionaly into
obturator, internal iliac and rarely into common iliac nodes.
8Innervation13
Bladder is richly innervated by autonomic nerves from the pelvic plexus. The
bladder wall is mainly supplied by Cholinergic nerves and the Trigone and
bladder neck are rich in Sympathetic supply.
Bladder and the Obturator nerve
The Obturator nerve runs over the Obturator internus muscle within the pelvis
and lies in close relation to the lateral walls of the distended bladder. The
surgical importance of this anatomy is that during endoscopic resection,
particularly TURBT, there is a chance for direct Galvanic stimulation during
activation of the loop which can lead to hazardous outcome. The Obturator
nerve supplies the adductor compartment of the thigh and activation of the
nerve during TURBT with consequent adduction of the limb can lead to bladder
injury by the active loop14.
Bladder Cancer
Bladder malignancy is the fourth and eighth common tumour in men and
women respectively. Also it is the 9th most common cancer worldwide1. It
accounts for 145,000 deaths worldwide. There has been upsurge in the
frequency of  Bladder cancer in Asia because increased prevalence of smoking.
Most common histological subtype Worldwide is Urothelial carcinoma except
9for Egypt where there is higher incidence of Squamous Cell Carcinoma due to
the endemicity of  Schistosomiasis. Age and environmental factors like smoking
are related to the development of Bladder cancer. The incidence is more
common in males than in females with a ratio of 3:1. Bladder cancer is less
frequent in younger age group (<40yrs) and tends to be low grade and non-
aggressive. Mean age of presentation is 70yrs in both the sexes and there is a
progressive increase in the incidence and death with advancing age15.
It is a well known fact that genetic abnormalities and external risk factors play a
major role in the development of bladder cancer. Smoking is considered as the
most common associated risk factor for the development of bladder cancer. A
diet which includes green leafy vegetables and fruits are considered to offer
some protection against bladder cancer16. The presence of low-penetrance genes
(NAT-2 and the GSTM1 polymorphisms) increases the susceptibility to
carcinogens and subsequent formation of bladder cancer. In endemic areas
infested with Schistosomiasis there is increased prevalence of Squamous Cell
Carcinoma in those areas, probably due to chronic inflammation as is same for
chronic catheterisation, long standing calculus and chronic inflammation.
Histologically, Urothelial carcinomas constitute about 90% of bladder cancers,
remainder 5% by Squamous cell carcinomas, and less than 2% by
Adenocarcinoma.  Overall Urothelial carcinoma is the commonest cancer of the
urinary tract and stands second in position next only to Renal cell carcinoma
10
leading to death in genitourinary tumors. About 80% of Urothelial tumors are
diagnosed early in patients when still the tumour is superficial and non–muscle
invasive15.
When cystoscopy is performed for bladder cancer, it is prudent to record the
location, size, number, and nature of the tumors. Urinary cytology is considered
as a basic outpatient test and obtained as a tool to identify the likelihood of
high-grade disease and aid in the follow-up of patients after definitive
management. Contrast imaging is done to stage the disease and to survey the
upper tracts since one of the theories behind the pathology of  Urothelial
carcinoma is “Field change cancerisation”17.
Management of  Bladder Cancer
The primary treatment for visible lesion is transurethral resection of the bladder
tumor (TURBT) under anesthesia with the aim to (1) resect all visible growth
and (2) obtain adequate specimens for histopathological grading and staging.
Bimanual examination of the bladder is most important step an Urologist should
do under anaesthesia prior and after resection and persistence of a palpable mass
after the surgery denotes peri-vesical spread17, 18.
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Historical milestones of Electrosurgery and the Resectoscope
Prehistoric man had the idea of using heated pebbles to control haemorrhage
and the idea of cautery is not new.  It was in the beginning of the eighteenth
century that the use of electrical energy came into use in the field of surgery.  It
was Goldwyn who classified the invention and development of electrosurgery
into three recognizable eras.  First is the period indistinctly etched in the history
with the use of static current.  No one knows when it began and who invented it.
Next period in the historical progression of electrosurgery is credited to Luigi
Galvani’s who in 1786 infact accidentally found that current could stimulate
muscle contractions. This period better known as “Galvanization era” is
considered as the birth of electrophysics. The last period which dates back to
1831 with the invention by Faraday and Henry that an electric current can be
produced by a fast moving magnet within a coil of wire19.
The fact that current at high frequency could pass through a patient’s body
without producing pain or burn was shown by Morton way back in 1881. It was
d’Arsonval who is considered as the “Father of  Electrosurgery” in 1891
showed when the frequency is set at 10 kHz, there was heating up of the tissue
with increasing proportion to the square of the density of current19.
Bovie is considered as the “Father of  Modern electrosurgery” by contributing
a diathermy unit capable of delivering high-frequency current. He also showed
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that this high frequency current could be used in surgery with the help of
Dr. Harvey Cushing on 1 October 1926 which is considered as an important
milestone in the history of electrosurgery19.
The Monopolar electrosurgical unit, called commonly as “Bovie”, is a routine
instrument in the modern day surgical armamentarium. The electrophysics of
Monopolar is well known.
The credit for the invention of a Bipolar unit goes to Dr. Malis in 1955. The
Malis bipolar unit worked at 1 MHz wavelength and required only 140V rather
than 2500V required by Monopolar system19.
The historical milestone in the technological inventions in the endoscopic
management of bladder tumours was the invention of Cystoscope by
Maximillian Nitze in 1877 which allowed Urologists to look into the bladder.
The ever first attempt at electroresection of  the bladder was by Beer in 1910. In
1926, Stern was the one who introduced resectoscope subsequent to which there
have been many modifications in the resectoscope design20.
The resectoscope designed by Stern-McCarthy was a rack and pinion model
instrument which was operated by both the hands and a tungsten loop slid front
and back to make the resection. It had an outer sheath which allowed irrigation,
passage of telescope and working element. With the Stern resectoscope sheath a
tubular cylinder of tissue was resected using high frequency current. Although
13
effective in resecting the prostatic mass, it was difficult to engage the bladder
tumours with this instrument20.
It was the efforts of McCarthy who modified the Stern resectoscope by
incorporating Bakelite to the tip of the sheath and thereby making it possible to
work when the current was applied and also prevented the risk of electric burns
to the operating surgeon21, 22.
Nesbit is regarded for his unique contribution of single handed spring action
working element which permitted safe resection23.
Even though the model proposed by Iglesias way back in 1979 is very much
similar to Nesbit, he is credited for the introduction of continuous flow
resectoscope sheath which speeded up the resection at the compromise of  larger
sheath size. The Iglesias sheath essentially had two sheaths, of which the larger
outer sheath was meant for drainage and smaller inner sheath for irrigation.
There are many advantages for this design in that it is operated by single hand,
loop is inside the sheath in resting position and moreover important advantage is
its unique continuous flow design which enabled it to keep the bladder pressure
low and a buy in the resection time20. Thus the incidence of TUR syndrome
should be theoretically low.
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Monopolar TURBT
TURBT can be performed under spinal or general anaesthesia. Whatever
anaesthesia is used, it should ensure adequate relaxation of the bladder and
abdominal wall5.
Before proceeding with the resection a thorough inspection of urethra, entire
bladder and both Ureteric orifices is done. The nature of the lesion, its location,
number, size (approximately comparable to loop diameter) and velvety-tan
areas suggestive of CIS are recorded. It is better to represent the tumour in a
pictorial fashion 24, 25.
The technique of  resection depends on the size of the lesion. Tumours less than
1cm can be resected in toto along with a good part of underlying muscle.
Tumours more than 1cm is usually resected piece meal starting from the
exophytic part to the base and then taking a separate specimen from the
underlying muscle. Deep resection specimen is sent for pathological analysis in
a separate container. It is shown in studies that there is high probability of under
staging in T1 tumours and most surgeons re-resect within 3weeks of primary
resection 24, 25.
15
B-TURBT
The surgical technique is essentially the same as in Monopolar. In Monopolar
electrosurgery the path of the electric current is from the active loop, then
through the tissues (patient), through the indifferent electrode placed abutting
the patient’s skin and back to the electro-surgical unit to complete the circuit.
The heat generated at the loop-tissue interface is used for resection.
In Bipolar electrosurgery, the large return electrode of the Monopolar mode is
replaced with a second small electrode. The path of the electric current is from
the active loop, through the conducting irrigant, through the patient’s tissue, to
the second indifferent electrode which is placed very close within the same loop
and then back to the electrosurgical generator. Two electrodes are combined in
the instrument. Current passes between tips and not through the patient. Hence,
there is no current flowing through the patient’s body.
Creation of plasma
In Bipolar resection, Current flows through the saline because impedance is
lower in saline than in body tissue.  Air bubbles are created around the loop by
the heat caused from current flow. The whole loop is covered by small bubbles.
Finally the loop is coated by an insulation layer. At this point Sodium ions are
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excited. Current is discharged to the air surrounding the electrode, similar to
lightning. Then the electrode is covered by plasma. Resection is made by the
heat of the plasma created around the electrode (Fig-1).
The colour of plasma formed due to saline is orange in colour and depends on
ion present in the irrigation fluid (Fig-3). The path of the current in resection
loop is from active electrode, through the saline, through the tissue and back to
the indifferent electrode close to active loop (Fig-2).
Fig-1 Formation of plasma
Fig-3 Orange Plasma Of SalineFig-2  Path of current
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A number of  Bipolar loop designs are available in the market depending on the
manufacturer (Fig-4).
GyrusStorz
Olympus
Active
Current path
Neutral
Current path
Current path
Neutral
NeutralActive
Active
The loops are designed so that both the electrodes are placed closely. The
Olympus system used the resectoscope sheath as the neutral electrode. The
Gyrus loops are so designed that the neutral electrode is incorporated into the
stem of the loop and active and neutral electrodes are separated by insulation.
In the Karl Storz model the indifferent loop is placed just opposite the active
loop and is much thicker than the active loop.
Fig-4 Various Bipolar Designs
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Complications
The incidence of complication after TURBT is reported to be around 5–6%.
The factors which are considered to lead to higher incidence of complications
are the size, number and location of the tumours. Bulkier, multifocal and
tumours in inaccessible regions like dome have higher rate of complication
during TURBT.  Hemorrhage is the most common complication occurring in 2–
3% of cases. Hemostasis achieved during TURBT and maintaining an empty
bladder reduces the incidence of bleeding postoperatively 26, 27.
A more dreadful complication of  TURBT is bladder perforation occurring in
about 1.3–3.5% of patients. Clinically insignificant micro-perforations go
unnoticed. Extraperitoneal perforations are common and are usually managed
by contiuous catheter drainage. Less frequent are intraperitoneal perforations
requiring open exploration and suture closure of the defect. The perforation can
occur as a result of obturator nerve stimulation, sudden muscle contraction and
rapid  jerky movement of the lower extremity. This obturator stimulation can be
prevented by obturator block, using GA with good muscle relaxants or replacing
energy soruce to bipolar electrocautery5, 28. It goes without saying that over-
distended bladder comes in proximity to obturator nerve and therefore the
surgeon should have tendency to resect with partially filled bladder.
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In M-TURBT, the high voltage is required to push the current from the active
electrode to the indifferent electrode as the distance between the two is greater.
In contrast to Monopolar systems, the energy and the voltage required by a
bipolar systems is much less because both active and indifferent electrode are
placed close to each other and current traverses only a small amount of
tissue28,29.
Theoretically no current should pass through the obturator nerve. But the initial
formation of plasma on activation of a bipolar loop requires high current. It is
often noticed that obturator jerks in bipolar resection occur during the initial
parts of resection, more so over when the tumour is located on the lateral wall.
Then further maintenance of plasma needs only a lower voltage. As there is less
charring and blackening of the tissue, vision is excellent allowing controlled
resection and subsequent avoidance of complications29.
The incidence of TUR syndrome is not noted with increased frequency in
TURBT  as  noted  in  TURP.  But  there  have  been  reports  quoting  to  have
documented higher incidence of TUR syndrome in few cases. Neverthless, it is
likely that during resection of large tumours some amount of fluid is likely to
get absorbed and can lead to dilutional hyponatremia. This incidence is less
when using Bipolar energy as saline is used as an irrigant instead of water or
glycine8.
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In monopolar systems, since the electrical energy is carried through the tissue,
resistance offered by the tissue elevates temperature to as high as 400oC which
leads to tissue damage and desiccation making difficulty in interpreting
pathological specimens30, 31.
But in bipolar energy, the radiofrequency current converts the conducting
irrigant into plasma which is at a higher temperature which dissociates the
bonds between the tissues reducing it into elementary molecules.
 Since the current is not completely running through the tissues and is circuited
through the closely placed indifferent electrode temperature rise in the tissues
resected is only modest (40 to 70oC) than during monopolar surgery and the
collateral spread is less30, 31. The depth of penetration is more in monopolar
resection when compared to bipolar resection.
Fig-5  MONOPOLAR
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In reviewing the literature, one study conducted by Geavlete B et al32 comparing
Bipolar energy and Monopolar energy for large non-invasive bladder tumours
have shown that the Bipolar resection was superior in that the operation time,
obturator nerve stimulation, hospital stay, bladder injury, hemolysis and post-
operative bleeding was significantly lesser than the Monopolar resection.
Another study conducted by Meneghini A et al33 noted that in Bipolar resections
there were no thermal artefacts in resected specimens which substantially
improved pathological interpretation through better evaluation of depth of
muscle penetration, angiolymphatic invasion and adjacent mucosa.
In another study conducted by Gupta et al29 comparing the Monopolar and
Bipolar resection of  Bladder tumours under low power setting have shown that
there is reduction of complications like obturator jerks, bladder perforation and
TUR syndrome.
Fig-6   BIPOLAR
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Yang SJ et al6 have shown that the complications are less with Bipolar resection
of  Bladder tumours in their study comparing the both. Also they noticed that
there was no difficulty in histopathological evaluation of specimens resected
using Bipolar energy. Bach T et al34 in their study on Bipolar resection showed
a decrease in resection time, decreased carbonisation of tissues and non-
stickiness of the tissues to the loops.
Kihl et al14 reported in their study of 160 Monopolar TURBTs noted 10.6%
incidence of adductor contraction. While McKiernan et al35 in their series noted
11% incidence of adductor response during Monopolar resections. But in case
of  Bipolar resection of bladder tumours Wang et al7 in their series of 11 patients
did not noticed any obturator reflex during  TURBT. Likewise Brunken et al36
also did not notice any obturator nerve stimulation during their surgery.
Thermal damage produced by the electrosurgery has been graded using the
WHO Grading7, 44 system (Appendix-3). It has been graded into four grades
according to the difficulty in identifying the cellular architecture and as the
grade increases the more is the difficulty in identifying the tissue architexture.
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WHO THERMAL DAMAGE GRADE
MONOPOLAR GRADE-1 BIPOLAR GRADE-1
BIPOLAR GRADE-2
BIPOLAR GRADE-3
MONOPOLAR GRADE-2
MONOPOLAR GRADE-3
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So, with all these added benefits of the Bipolar energy, a study was conducted
to evaluate the Safety and Efficacy of Bipolar energy source in TURBT in
comparison to Monopolar TURBT and also to study the thermal artefacts
produced by both the energy sources on resected specimens.
25
MATERIALS & METHODS
The following are the materials and methods employed for the present
study titled “SAFETY AND EFFICACY OF BIPOLAR ENERGY FOR
TRANSURETHRAL RESECTION OF BLADDER TUMORS”
Period of study:
The study is done between March 2012 and Feb 2013
Type:
This is a prospective study evaluating the safety and efficacy of bipolar
energy in TURBT
Place:
The study is conducted in the Department of Urology, Rajiv Gandhi
Government General Hospital & Madras Medical College, Chennai.
Inclusion criteria
All patients diagnosed to have Bladder tumour by Ultrasonography,
CECT and Cystoscopy
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Exclusion criteria
? Patients with coagulopathy
? Seriously ill patients
? Tumours with perivesical extension and metastases
? Patients with elevated renal parameters
Method of Study
Institutional Ethics Committee approval was obtained. Informed consent
was taken from all patients. All details were recorded as per the Proforma
(Appendix-1). Patients were randomized into two groups of 50 each to undergo
TURBT either Monopolar (Group 1) or Bipolar (Group 2). Patients either
underwent Monopolar or Bipolar TURBT in Glycine and Saline respectively.
We used the Gyrus ACMI PK system and used PK thin loop for resection. The
settings we employed were 160W cutting and 80W coagulation respectively for
Bipolar  resection. Martin ME MB2 monopolar system was used for Monopolar
resection at the setting of 120W cutting and 60W coagulation.
The setup of  instruments for Monopolar TUR resection  is well known. But the
setup for Bipolar TUR resection is essentially the same with certain
modifications.
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The working element is modified and has no shaft. There is a modified slot for
engaging the Bipolar loop. The working element is provided with an adaptor so
that it can fit into the regular resectoscope sheath. The Bipolar loop is also
modified from the conventional Monopolar loop. It is much sturdier to
compensate for the shaft which is absent in working element. The high
frequency cable is integrated into the loop. So loop cannot be separated from the
cable. There is also a leak proof  wiser present in the shaft of the loop. The basic
setup for bipolar resection is given in the figure below.
GYRUS ACMI PK SYSTEM
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BASIC SET-UP
TECHNIQUE TO ENGAGE THE LOOP
MODIFIED WORKING
ELEMENT
Fully Assembled Sheath
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Preoperative workup
Exhaustive clinical history was taken from all patients. Co-morbid
conditions like Hypertensiona and Diabetes Mellitus were documented.
All basic blood and urine investigations were done in the pre-operative
period. Urine culture was done in all patients and appropriate antibiotics were
started. Ultrasonogram of KUB region was done to assess the site, number,
nature, size and to survey upper tracts. CECT KUB was done in all patients to
note extravesical presence of  urothelial tumours and to assess the loco-regional
extent (Staging).
Procedure
All the resections were performed by our Senior Professor who was very
experienced in performing TURBT. A 24-F Karl Storz non-continuous flow
resectoscope was used with either glycine or saline irrigation for Monopolar
TURBT (Group 1) and for Bipolar TURBT (Group 2).
All patients after exclusion criteria were subjected to either Monopolar or
Bipolar TURBT. Spinal anaesthesia without any nerve block was used and
patients underwent the procedure in Lithotomy position. Preliminary cystoscopy
was done to assess the urethra, prostate gland, and the nature, size, location and
multiplicity of bladder tumous. Using 24F non-continuous Karl Storz
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resectoscope sheath and Baumrucker type active working element TURBT was
performed in both groups.
Tumour resection was done in a step by step manner starting from the
summit of  the tumour so as to deflorate reaching the stalk or the base. Once the
base was resected, the underlying muscle was resected separately. The two
specimens superficial and deep were put in separate containers and sent for
histopathological examination. After completion of the procedure all the
bleeding points were coagulated and hemostasis secured. We routinely used a
22Fr three way Foley catheter for drainage and irrigation. Irrigation with saline
was given for first 12hours or till clear urinary drainage was seen.
The resection time was calculated from the period of initiation of
resection to the removal of resectoscope sheath. For every patient, resection
time, volume of irrigation, obturator jerks, perforation, TUR syndrome, Post-
operative Hemoglobin, sodium, dry specimen weight and catheterization period
were recorded. Patients were discharged on the day of catheter removal.
We sent the specimens to our pathology department in two separate containers
labelled as Superficial and Deep on the containers. It was processed and
examined by a Senior professor in pathology. Tumours were examined for
histology, invasion of  Lamina or Detrusor. Additionally specimens were
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assessed for thermal artefacts produced by both Monopolar and Bipolar energy
sources as per WHO grading .
WHO Thermal Injury Grading
Degree of thermal damage Characterization
0 No thermal damage
1 Lowest grade of thermal artifacts. The
cellular structure is identifiable and not
impaired
2 Medium grade. Cellular structure and
nuclei are impaired, but still identifiable
3 High grade artifacts. Complete loss of
the cellular structure.
No differentiation of the cellular parts
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OBSERVATION AND RESULTS
As a whole 145 patients underwent TURBT for bladder tumour during the study
period. Out of  these 145 patients, 45 patients were excluded from the study due
to various reasons like  locally advanced disease as detected by CECT,  elevated
renal parameters and  anticoagulants use which could not be withdrawn for
medical reasons. So, after excluding these 45 patients, rest   underwent TURBT
either with Monopolar or Bipolar energy (Fig-6).
145 patients with CA
bladder
100 patients
eligible
Exclusion
criteria
TURB
T
Bipolar TUR
50
Group 2
Monopolar TUR
50
Group 1
Fig-6 Patient Randomisation
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Pre-operative parameters of both Group 1 and Group 2 are presented in Table 1
and 2 respectively.
Table-1    Patient and Tumour Demography (M-TURBT)
Table-2     Patient and Tumour Demography (B-TURBT)
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Group 1(M-TURBT)
In whole, 50 patients with Bladder tumours were subjected to Monopolar
resection. There were tumours in 45 men and 5 women. Age range of the
patients was between 40 and 76yrs with a mean of 58.2+8.45yrs. History of
tobacco abuse in the form of smoking/chewing was present in 37(74%) patients.
Comorbidities were present either in the form of Diabetes in 14(28%) or
Hypertension in 17(34%). When the tumour multiplicity was considered, 4(8%)
patients had multifocal disease and remainder 46 (92%) patients had solitary
lesions. The distribution of the tumour was 31 in the lateral wall, 1 in anterior
wall, 14 in trigone and 7 in dome.
Mean  ±  SD tumour  size  was  20.6±7.5  mm.   The  Mean  drop  in  PCV after  the
procedure was 2.38±0.83.  The Mean drop in sodium after the procedure was
3.2 ± 1.76  mEq/L with no patient developing TUR syndrome. The mean time
to resect the tumours was 24.84+ 4.75mins.   Perforation of the bladder was
noted in 3cases. There were totally 10 pateints having Obturator jerks in all of
50 patients, either occurring singly or multiple times in a same patient (20%)
with a mean of 0.32. The mean specimen weight was 1.52+ 0.47gms. We
discharged the patient once the hematuria via Foley settled and on the day of
catheter removal. So the mean hospitalization after the procedure was 2.56+1.88
days. When the thermal artefact grade was analysed the mean grade was 1.42
(Table 3).
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Table-3 Intraoperative and Post-operative parameters (M-TURBT)
Monopolar N Mean Std. Dev Min Max 1
st
Quartile Median
3rd
Quartile
Difference in
PCV(%) 50 2.38 0.83 1.0 4.0 2.0 2.0 3.0
HEMOGLOBIN
DEFICIT(gms%) 50 0.42 0.23 0.1 1.2 0.2 0.4 0.6
SODIUM
DEFICIT(meq/l) 50 3.20 1.76 1.0 8.0 2.0 3.0 4.0
RESECTION
TIME(mins) 50 24.84 4.75 14.0 38.0 21.8 25.0 26.3
OBTURATOR
JERK 50 0.32 0.71 0.0 3.0 0.0 0.0 0.0
SPECIMEN
WEIGHT (gms) 50 1.52 0.47 1.0 3.0 1.0 1.5 2.0
THERMAL
ARTEFACT
GRADE
50 1.42 0.70 0.0 2.0 1.0 2.0 2.0
The Histopathological examination of the tissue specimens yielded a diagnosis
of  Transitional Cell Carcinoma in 48 patients. Out of this 48 transitional cell
carcinoma Papillary histology was found in 17, Low-grade T1 in 16, High-
grade T1 in 12 and Muscle invasive in 3 specimens.  The histopathology of two
specimens turned out to be Adenocarcinoma and Squamous Cell Carcinoma one
in each respectively. All the specimens were examined and reported without any
difficulty.
 Forty eight patients received post operative instillation of Mitomycin-c within
6hours. Twelve patients received induction dose of  intravesical BCG and five
patients were subjected to Radical Cystectomy. Out of this five patients, 3 had
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detrusor invasion, 1 had Squamous Cell Carcinoma and 1 had Adenocarcinoma
(Table-4)
Table-4 Histopathology (M-TURBT)
Variable N
Stage 50
Ta 17(34%)
T1 Low grade 16(32%)
T1 High grade 12(24%)
T2 03(6%)
Histopathology
TCC 48(96%)
Adenocarcinoma 01(2%)
SCC 01(2%)
Intravesical Therapy
Mitomycin-c 48
BCG 12
Radical Cystectomy 05
Group 2(B-TURBT)
In whole, 50 patients with Bladder tumours were subjected to Bipolar
resection. There were tumours in 44 men and 6 women. Age range of the
patients was between 32 and 80yrs with a mean of 56.5+10. History of tobacco
abuse in the form of smoking/chewing was present in 35 (70%) patients. Co-
morbidities were present either in the form of Diabetes in 15 (30%) or
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Hypertension in 18 (36%). When the tumour multiplicity was considered
5(10%) patients had multifocal disease and remainder 46 (92%) patients had
solitary lesions. The distribution of the tumour was 42 in the lateral wall, 2 in
anterior wall, 10 in Trigone and 4 in dome.
Mean ± SD tumour size was 21.68±7.64 mm. The Mean drop in PCV after the
procedure was 1.22±0.46.  The Mean drop in sodium after the procedure was
3.02 ± 1.67 mEq/L with no patients developing TUR syndrome.  No Perforation
of the bladder was noted. The mean resection time was 33.72+2.36mins.
 There were totally 4 patients having Obturator jerks in all the 50 patients (8%)
with  a  mean  of  0.08.  The  mean  weight  of  the  resected  specimen  was
1.69+0.60gms. When we analysed the thermal artefacts the mean approached
0.54. We discharged the patient once the hematuria via Foley settled and on the
day of catheter removal. So the mean hospitalization after the procedure was
2.1+0.36 days (Table 5).
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Table-5 Intraoperative and Post-operative parameters (B-TURBT)
Bipolar N Mean Std. Dev Min Max
1st
Quartile Median
3rd
Quartile
Difference in
PCV(%) 50 1.22 0.46 1.0 3.0 1.0 1.0 1.0
HEMOGLOBIN
DEFICIT(gms%) 50 0.37 0.20 0.1 0.8 0.2 0.4 0.6
SODIUM
DEFICIT(meq/l) 50 3.02 1.67 1.0 7.0 2.0 2.0 4.0
RESECTION
TIME(mins) 50 33.72 2.36 30.0 40.0 32.0 34.0 35.0
OBTURATOR
JERK 50 0.08 0.27 0.0 1.0 0.0 0.0 0.0
SPECIMEN
WEIGHT (gms) 50 1.69 0.60 1.0 3.0 1.1 1.5 2.0
THERMAL
ARTEFACT
GRADE
50 0.54 0.68 0.0 2.0 0.0 0.0 1.0
The Histopathological examination of the tissue specimen yielded a diagnosis of
Transitional Cell Carcinoma in 49 patients. Out of this 49 transitional cell
carcinoma Papillary histology was found in 23, Low-grade T1 in 16, High-
grade T1 in 08 and Muscle invasive in 2 specimens.  The histopathology of one
specimen turned out to be Squamous Cell Carcinoma. All the specimens were
examined and reported without any difficulty.
Forty nine patients received post operative instillation of Mitomycin-c within
6hours. Eight patients received induction dose of intravesical BCG and three
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patients were subjected to radical Cystectomy. Out of this three, 2 had detrusor
invasion and 1 had Squamous Cell Carcinoma.
Table-6 Histopathology(B-TURBT)
Variable N
Stage 50
Ta 23(46%)
T1 Low grade 16(32%)
T1 High grade 08(16%)
T2 02(4)%
Histopathology
TCC 49(98%)
Adenocarcinoma 00
SCC 01(2%)
Intravesical Therapy
Mitomycin-c 49
BCG 08
Radical Cystectomy 03
Thermal Artefact
Thermal artefacts were graded according to WHO grading system (Appendix
3). There was no difficulty noticed during histopathological examination of
resected specimens.
 In Monopolar group, there were 27(54%) grade 2 thermal damage, 17(34%)
grade 1 thermal damage and no grade-3 thermal damage in examined specimen.
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In Bipolar group, there were 07(14%) grade 2 thermal damage, 12(24%) grade 1
thermal damage and no grade 3 thermal damage in examined specimen
Table-7  WHO Thermal Damage Grading39
M-TURBT B-TURBT
Grade 0 (%) 6(12%) 31(62%)
Grade 1 (%) 17(34%) 12(24%)
Grade 2 (%) 27(54%) 07(14%)
Grade 3 (%) 0 0
Complications
Three patients in Monopolar group had bladder perforation. Two of them
were extraperitoneal and were managed by prolonged catheter drainage. One
patient underwent exploratory laparotomy and closure of the perforation. None
of the patients in the bipolar group had perforation and no patient in either
group required blood transfusion or developed TUR syndrome.
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Comparative Statistical analysis of M-TURBT & B-TURBT
The comparison of mean values of continuous and categorical variables was
done using the Student’s t-test and the chi-square test respectively. If the p value
is <0.05, the result is considered statistically significant.
The mean age of the patients in both M-TURBT and B-TURBT was
comparable and when analysed statistically did not reach significance (p=0474).
Variable
Group N Mean
Std.
Deviation
P-Values
Age (years) Monopolar 50 58.86 8.45
0.474
Bipolar 50 57.50 10.38
42
The both the groups were comparable in the distribution of sexes and analysis
did not reveal any statistical difference(p=0.538).
Gender Group Total
Monopolar Bipolar
N % N % N %
Male 45 90.0 43 86.0 88 88.0
Female 5 10.0 7 14.0 12 12.0
Total 50 100.0 50 100.0 100 100.0
Chi-Square Tests P-Value
Pearson Chi-Square 0.538
The association of smoking with bladder cancer was also assessed. Eventhogh
there was high incidence of tobacco abuse within each group there was no
statistically significant difference between the two groups(p=0.656).
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Smoking Group Total
Monopolar Bipolar
N % N % N %
No 13 26.0 15 30.0 28 28.0
Yes 37 74.0 35 70.0 72 72.0
Total 50 100.0 50 100.0 100 100.0
Chi-Square Tests P-Value
Pearson Chi-Square 0.656
The co-morbidities associated with bladder cancer were also studied and both
the groups were comparably matched without any statistical difference.
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HYPERTENSION Group Total
Monopolar Bipolar
N % N % N %
No 33 66.0 32 64.0 65 65.0
Yes 17 34.0 18 36.0 35 35.0
Total 50 100.0 50 100.0 100 100.0
Chi-Square Tests P-Value
Pearson Chi-Square 0.834
DIABETES Group Total
Monopolar Bipolar
N % N % N %
No 36 72.0 35 70.0 71 71.0
Yes 14 28.0 15 30.0 29 29.0
Total 50 100.0 50 100.0 100 100.0
Chi-Square Tests P-Value
Pearson Chi-Square 0.826
Most important of all, the means of variables were compared between the two
energy sources to know the difference between them and its significance. The
results of the t-test are given below. The packed cell volume (PCV), resection
time, obturator jerks and thermal artefact grades had significant values.
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The difference in PCV was much lesser in Bipolar group than Monopolar
(p=0.001).
Variable
Group N Mean
Std.
Deviation
P-Values
Difference in PCV Monopolar 50 2.38 0.83
0.001
Bipolar 50 1.22 0.47
The resection time between groups also reached significance with prolonged
time in Bipolar (p=0.001).
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Variable
Group N Mean
Std.
Deviation
P-Values
RESECTION TIME Monopolar 50 24.84 4.75
0.001
Bipolar 50 33.72 2.36
The obturator jerks were more in Monopolar group with statistically significant
values (p=0.029)
Variable
Group N Mean
Std.
Deviation
P-Values
OBTURATOR JERK Monopolar 50 0.32 0.71
0.029
Bipolar 50 0.08 0.27
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Likewise when analysing the thermal damage it was seen that there were more
artefacts in Monopolar group(p=0.001)
Variable
Group N Mean
Std.
Deviation
P-Values
THERMAL
ARTEFACT GRADE
Monopolar 50 1.42 0.70
0.001
Bipolar 50 0.54 0.68
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The haemoglobin deficit, sodium deficit and resection specimen weight between
the groups did not reach statistical significance even though there was
difference in the values.
Variable
Group N Mean
Std.
Deviation
P-Values
HEMOGLOBIN
DEFICIT
Monopolar 50 0.42 0.23
0.248
Bipolar 50 0.37 0.20
SODIUM DEFICIT Monopolar 50 3.20 1.76
0.601
Bipolar 50 3.02 1.67
SPECIMEN WEIGHT
(gms)
Monopolar 50 1.52 0.47
0.107
Bipolar 50 1.69 0.60
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When the location of the tumours were compared between the two groups there
was no difference (p=0.435).
LOCATION
OF
TUMOURS
Group Total
Monopolar Bipolar
N % N % N %
L 25 50.0 32 64.0 57 57.0
PW 2 4.0 3 6.0 5 5.0
T 15 30.0 9 18.0 24 24.0
D 7 14.0 4 8.0 11 11.0
AW 1 2.0 2 4.0 3 3.0
Total 50 100.0 50 100.0 100 100.0
Chi-Square Tests P-Value
Fisher's Exact Test 0.435
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DISCUSSION
Bladder malignancy is the fourth and eighth common tumour in men and
women respectively1. It accounts for 145,000 deaths worldwide. There has been
an upsurge in the frequency of bladder cancer in Asia because of increased
prevalence of smoking. Most common histological subtype worldwide is
Urothelial carcinoma except for Egypt where there is higher incidence of
Squamous cell carcinoma due to the endemicity of  Schistosomiasis. Mean age
of presentation is 70yrs in both the sexes and there is a progressive increase in
the incidence and death with advancing age15.
Overall Urothelial carcinoma is the commonest cancer of the urinary tract and
stands second in position next only to Renal cell carcinoma leading to death in
genitourinary tumors. About 80% of Urothelial tumors are diagnosed early in
patients when still the tumour is superficial and non–muscle invasive15.
The most important fact when dealing with Bladder tumours is that they tend to
reccur and progress. The important variables that should be considered in the
risk stratification of the patients should include tumour multifocality, size,
grade, stage, CIS and history of previous recurrence18.
It is proven that Grade of the tumour is more important in predicting the
prognosis rather than stage in Urothelial cancers.  The size of the tumour,
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multifocality, nature of the tumour (Sessile vs Pedunculated) and the presence
or absence of angiolymphatic permeation also determines the prognosis37.
Worldwide there are cultural and environmental differences in the nature of
food, degree of exposure and the presence or absence of susceptility genes for
carcinogenesis and this factor could contribute to reccurrence16.
The TNM system which is commonly used for most tumours is also used for
Bladder cancer staging.  Elsewhere, TNM staging includes size and multiple
natures of  the tumours for staging. But in Urothelial tumours of the Bladder the
‘T’ stage is determined by the depth of penetration rather than size and
multifocality.  Tumor size and multiplicity are not included in the TNM staging
of bladder cancer. But without question size and multifocality are important
prognosticators38.
When cystoscopy is performed for Bladder cancer, it is prudent to record the
location, size, number, and nature of the tumors. Contrast imaging is done to
stage the disease and to survey the upper tracts since one of the theories behind
the pathology of  Urothelial carcinoma is “Field change cancerisation”17. The
primary treatment for visible lesion is transurethral resection of bladder tumor
(TURBT).
In 1910 Beer was the first to do an endoscopic resection of bladder tumour.
Since then TURBT has remained the basic diagnostic and often therapeutic tool
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for Bladder tumours8. Conventionally, Monopolar loop resection of the Bladder
tumours have been and are being done using non-conducting irrigation solutions
such as sterile water, 1.5% glycine and other alternative fluids. Sterile water has
many advantages for an optimal irrigant such as better field of vision, cheap and
non-conducting. But there is some amount of water intravasation into blood
circulation which can lead to osmotic lysis of red cells and dilutional
hyponatraemia39.  So to reduce this effect but not exclude non-hemolytic
solutions are being used. But even these irrigants are not isotonic, so the
incidence of hyponatremia still exists. But these irrigants for monopolar comes
at a cost.
Saline is safer than water in many ways in it, that it is physiological, has
equivalent visibility comparable to water, less expensive, isosmotic with plasma
and is considered as the irrigant of choice for endoscopic procedures.  But this
irrigant cannot be used in Monopolar resections as the current will be carried by
the saline without any tissue effect40. With technological advance, invention of
Bipolar electrosurgery, it became possible to use physiological solution such as
Saline for resection.
Bipolar electroresection in Saline for the above mentioned reasons avoids the
risk of  TUR syndrome. This is mainly because even if  large amounts of Saline
is absorbed, it is isotonic and does not lead to dilutional Hyponatremia41.
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Whenever transurethral resection is being done, the tissue venous and lymphatic
channels are opened up and since the irrigation is done under positive pressure
it is understood that irrigant is bound to enter into these channels, thereby
leading to aforementioned complications. The degree of absorption of fluid is
dependent upon many factors. The height of the irrigant, surface area of
resected area, resection time, type of the irrigant used and of course the number
of venous channel opened.
In a study conducted by Hahn et al regarding endoscopic resection of  Bladder
tumours, using Monopolar energy (M-TURBT) first reported the incidence of
TUR syndrome in four patients. Subsequently, there are few literatures in
published literature reporting the syndrome with an average incidence of 2%
Monopolar TURBT42. But when it comes to Bipolar TURBT there is even lesser
number of studies reporting the incidence of TUR syndrome.
 In our study if we take the incidence of  TUR syndrome, even though there was
a biochemical evidence of minor drop in the level of sodium in M-TURBT,
none of the patients had symptoms of Dilutional Hyponatremia. Moreover the
statistical analysis of the difference in the sodium levels did not reach
significance (p=0.30).  When we consider the incidence in B-TURBT, even
though there were minor alterations in the sodium levels, none of the patients
developed symptomatic TUR syndrome. When we compared the mean sodium
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drop between Monopolar and Bipolar TURBT, it did not reach statistical
significance (p=0.601). This seems to be due to the less venous channels opened
during resection in comparison to TURP and the resection time is much shorter
than for TURP. So whatever energy source is used the incidence of TUR
syndrome seems to be negligible.
 When it comes to the incidence of obturator jerks, it is much lesser in Bipolar
resections compared to Monopolar resections. In a study comprising of 160
resections, Kihl et al reported obturator jerks in 10.6% of cases employing
Monopolar energy14.Another similar study by McKiernan et al. notified
obturator reflex in 11% of their patients using Monopolar energy35.
 In our study, the incidence of obturator jerks in Monopolar TURBT was 20%
and the incidence of jerk in Bipolar TURBT was 8%. But the number of jerks
was more in Monopolar group and occurred more number of times in some
patients. All the jerks noted in Bipolar group were single. When we analyzed
the two group there was a statistically higher incidence of  jerks in M-TURBT
(p=0.029).
In a study conducted by Wuand et al  using Bipolar TURBT at a power setting
of 160watts for cutting and 80watts for coagulation mode employing 121
patients  reported an overall complication rate of  13.2%,  with  2.5%  patients
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developing significant haematuria mandating blood transfusion, 1.7% incidence
of  bladder perforation and 4.9% incidence of  obturator jerks43.
If we consider our study, we also used the same settings none of our patients
needed transfusion for, none had bladder perforation and we noticed obturator
jerks in 8%. We noticed that the jerks were common when the tumour was
located in the lateral walls and all of them occurred during the initial activation
of the loop. None of the jerks occurred during the actual resection. Similarly, a
study conducted by Gupta et al using low power settings, have noticed a
decrease number of jerks and also the jerks were noticed during the activation
of the loop29.
One of the quoted advantages in literature is that, there is lesser degree of
carbonisation and darkening while resecting bladder tumours employing Bipolar
energy which allows excellent visualization of the residual tumour tissue after
resection allowing complete resection29.
The specimen after resection from B-TURBT is comparable from a histological
point of view to that obtained using M-TURBT, with few advantages of the
Bipolar resection specimens showing lesser thermal damage. Yang SJ et al have
done a study to assess the deep tissue damage comparing Monopolar and
Bipolar TURBT and did not find any difficulty in histopathological diagnosis
between both energy sources6.  When we examined our specimens, there was
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increased number and degree of artefacts noticed in Monopolar resections than
bipolar resections when graded using WHO grading (Appendix 3). But grade-3
thermal artefact was not noticed in both M-TURBT and B-TURBT. All the
artefacts noticed in the B-TURBT were Grade-1 and most of the M-TURBT
specimens showed grade-2 artefacts. On statistical analysis it was shown that
Bipolar is superior in preserving the cytoarchitexture (p=0.001)
When operating on high risk group like patients with pacemakers, cardiac
diseases, unstable angina and patients with decreased pulmonary reserve it is
shown that bipolar resection is much safer than Monopolar resection29.
When the resection time was considered, the mean resection time was more
with the use of  Bipolar energy(p=0.001) which was statistically significant.
This may be explained from the fact that the formation of plasma on activation
of the loop has a lag period of few milliseconds, which is experienced by the
surgeon in reality. Secondly, slower the loop is moved, better is the hemostasis.
To gain on the hemostatic effect of the bipolar energy, it is accepted to lose time
during resection. Third factor is that, the surgeon has the tendency to go easy
during resection since he is already aware that saline is being used.
57
CONCLUSION
The conclusions that can be drawn from this study are
? Bipolar resection of Bladder tumours have lower incidence of
complications especially bleeding, TUR syndrome, obturator jerks and
bladder perforation.
? The degree of thermal damage is much lesser in histological sections and
interpretation of the grade which is one of the most important
prognosticators especially in bladder tumours since high grade lesions are
proven beyond doubt to progress and reccur.
? Bipolar TURBT is safe and efficacious in managing bladder tumours.
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APPENDIX-1
PROFORMA
        Safety and efficacy of bipolar energy in Transurethral resection of
bladder tumours
Name Smoking/Tobacco
Age DM/HTN/TB
Sex Previous Surgery
Hospital NO
Ultrasound KUB
Right Left
Kidney
Bladder
Prostate
Pre-op haemoglobin
Post-op haemoglobin
Difference in hemoglobin
Pre-op electrolytes
Na+
K+
Cl-
Post-op electrolytes
Na+
K+
Cl-
CECT KUB Cystoscopy
Site Site
Size Size
Number Number
Sessile/ Pedunculated Sessile/ Pedunculated
Lymphnode
Upper Tracts
TURBT
Monopolar/bipolar Irrigant   Glycine/saline
Resection time Irrigation volume
Resected specimen weight TUR syndrome
Obturator reflex Bladder perforation
HPE
APPENDIX-2
INFORMED CONSENT FORM
Title of the study:   “ Safety and efficacy of bipolar energy in Transurethral resection of
bladder tumours”
Name of the Participant:
Name of the Principal (Co-Investigator): Dr. Vasudevan T
Name of the Institution: Rajiv Gandhi Govt General Hospital, Chennai – 3
Documentation of the informed consent
I _____________________________ have read the information in this form (or it has been read to
me). I was free to ask any questions and they have been answered. I am over 18 years of age and,
exercising my free power of choice, hereby give my consent to be included as a participant in the
study on “Safety and efficacy of bipolar energy in Transurethral resection of bladder tumours”
1. I have read and understood this consent form and the information provided to me.
2. I have had the consent document explained to me.
3. I have been explained about the nature of the study.
4. I have been explained about my rights and responsibilities by the investigator.
5. I have been informed the investigator of all the treatments I am taking or have taken in the past 3
months including any native (alternative) treatment.
6. I have been advised about the risks associated with my participation in this study.
7. I agree to cooperate with the investigator and I will inform him/her immediately if I suffer unusual
symptoms.
8. I have not participated in any research study within the past 6 month(s)
10. I am aware of the fact that I can opt out of the study at any time without having to give any reason
and this will not affect my future treatment in this hospital.
11. I am also aware that the investigator may terminate my participation in the study at any time, for
any reason, without my consent.
12. I hereby give permission to the investigators to release the information obtained from me as result
of participation in this study to the sponsors, regulatory authorities, Govt. agencies, and IEC. I
understand that they are publicly presented.
13. I have understand that my identity will be kept confidential if my data are publicly presented
14. I have had my questions answered to my satisfaction.
15. I have decided to be in the research study.
I am aware that if I have any question during this study, I should contact the investigator. By signing
this consent form I attest that the information given in this document has been clearly explained to me
and understood by me, I will be given a copy of this consent document.
For adult participants:
Name and signature / thumb impression of the participant (or legal representative if participant
incompetent)
Name _________________________ Signature_________________ Date________________
Name and Signature of impartial witness (required for illiterate patients):
Name _________________________ Signature_________________ Date________________
Address and contact number of the impartial witness:
Name and Signature of the investigator or his representative obtaining consent:
Name _________________________ Signature_________________ Date________________
??????? ?????????
?? ?? ??????????????????? ? ?????????? ???? ?????????????????????
???? : ???? :
??? : ???????????? :
??? : ??????? ????????? :
???? ??????? ? ? ?? ?????? ???? ??????? ???????? ????? ???? ??
?? ???????.
????? ?? ??????? ?? ?????? ???? ????? ?????? ???? ???????
????? ?? ??.
???? ?? ?? ????? ??????? ????? ?? ? ??? ?????? ????? ??????? ?
???????????????? ??????????????????????????????????? ?? ??.
???? ??????? ? ? ?? ??? ???????? ?? ??? ?????? ?? ????? ? ????? ???
???????? ??? ????? ???? ??????? ? ? ????? ???????? ?? ? ???????? ???????
?????????????? ??????????????????????????????????.
?? ?? ????? ??????? ????? ?? ? ??? ??? ?? ???? ??????? ? ? ?? ?????
????????????????????????????.
???? ??????? ??? ?? ?????? ????? ??? ????? ?????? ???? ?????
??????? ? ??????????????????????? ?? ??.
???? ??????? ? ? ?????????? ????????? ??? ? ?? ???????? ???
????????????????????? ?? ??. ??????????????? ? ?????????????? ?? ??.
????????????? : ?????????????????
? ) ?????????????????
??????????? : ???????????????
??? :
???? :
??????? ???????
?? ?? ???????????? ??????? ? ?????????? ???? ?????
???????????????
????? ??? ?? ???????????? ??????? ? ?????? ???? ????
?????????????.
???? ????? ???? ????? ???????? ? ? ???????? ???????
????????????? ? ??????? ??????????? ???????????? ?.
?? ?? ????  ??????? ????? ?? ? ??? ?????? ??? ?
?? ?????????????????????????? ? ??????????.
?? ??? ???? ??????? ? ? ??????? ?????? ?? ???? ???. ???
??????? ? ? ????? ?? ???????? ????????? ???? ?????????
????? ?? ? ???? ? ????????? ????????. ?????? ?????
?? ? ????????????? ?????????????????????????????? ???.
???? ??????? ? ? ??????? ????? ???????? ???? ? ?
??????? ????? ??????? ? ? ??????? ?????? ????????? ????
?????????????? ???? ? ? ???????? ???????? ???????
?????? ???.
??????????? ? ??????????????????? ????? ? ????????
????? ?.  ????? ?? ??? ???????? ???? ??????? ? ? ????? ??
?????????????????????????????? ???.
??????? ???????????? ??????????????????
????
Appendix-3
WHO THERMAL DAMAGE GRADE
Degree of thermal damage Characterization
0 No thermal damage
1 Lowest grade of thermal
artifacts. The cellular structure
is identifiable and not impaired
2 Medium grade. Cellular
structure and nuclei are
impaired, but still identifiable
3 High grade artifacts. Complete
loss of the cellular structure.
No differentiation of the cellular
parts
APPENDIX-4
ETHICAL COMMITTEE APPROVAL FORM
MASTER CHART-MONOPOLAR
Pre-operative Post-operative CECT CYSTOSCOPY TURBT-M HPE
SL
No Name Age Sex Smoking HTN DM  Hb PCV Na  Hb PCV PCVD HbD Na NaD L S(mm) N M UT LN L N M IR IV RT OJ SW TURS PERF CP HISTO TAG
1 GOVINDAN 60 M YES NO NO 10.6 32 146 10.2 30 2 0.4 142 4 PW 12 1 Ped N NO PW 1 Ped Gly 2000 21 0 1 NIL NIL 2 LGT-Ta 0
2 SOLAIVANNAN 42 M YES NO NO 9.6 28 138 9 26 2 0.6 132 6 LL 22 1 Ped N NO LL 1 Ped Gly 3000 24 1 1.6 NIL NIL 2 LGT-Ta 1
3 VELAYUTHAM 53 M YES NO NO 9.8 30 130 9.2 28 2 0.6 128 2 LL, RL 11 2 Ped N NO
LL,
RL 2 Ped Gly 3500 26 0 1 NIL NIL 2 LGT-T1 2
4 PARIVENTHAN 58 M YES NO NO 10.2 32 142 9.4 31 1 0.8 140 2 D 23 1 Ped N NO D 1 Ped Gly 3000 23 0 1.4 NIL NIL 2 LGT-Ta 0
5 ILANGOVAN 54 M YES YES NO 12.6 36 138 11.4 32 4 1.2 132 6 PW 31 1 Ped N NO PW 1 Ped Gly 3500 31 0 2 NIL NIL 2 LGT-T1 2
6 GEETHALAXMI 53 F NO NO NO 9.6 26 138 9.4 24 2 0.2 130 8 T 22 1 Ped N NO T 1 Ped Gly 3000 24 0 1.5 NIL NIL 2 HGT-T1 1
7 SILAMBAN 48 M YES YES NO 10.4 32 134 9.8 30 2 0.6 130 4 LL 32 1 SES N NO LL 1 SES Gly 3500 25 2 1.7 NIL NIL 2 HGT-T2 2
8 SEKAR 52 M YES YES YES 11.2 34 134 11 30 4 0.2 130 4 RL 12 1 Ped N NO RL 1 Ped Gly 2000 18 0 1 NIL NIL 2 LGT-Ta 0
9 MOHANAVEL 58 M NO YES NO 12 35 144 11.4 31 4 0.6 140 4 D 24 1 Ped N NO D 1 Ped Gly 3500 25 0 1.5 NIL NIL 2 LGT-Ta 1
10 SIDDAPPA 66 M YES YES YES 9.8 28 138 9.2 26 2 0.6 135 3 LL 34 1 SES N NO LL 1 SES Gly 3500 25 0 2.3 NIL YES 10 HGT-T2 2
11 CHOKKALINGAM 59 M NO NO NO 10.6 30 135 10 28 2 0.6 132 3 T 14 1 Ped N NO T 1 Ped Gly 2000 21 0 1 NIL NIL 2 LGT-Ta 1
12 BOMMAIAN 52 M YES NO NO 12 34 142 11 32 2 1 138 4 T 33 1 Ped N NO T 1 Ped Gly 3500 32 0 2.5 NIL YES 10 HGT-T1 2
13 MUTHALIK 58 M YES YES NO 10.2 31 134 9.6 28 3 0.6 132 2 D 22 1 Ped N NO D 1 Ped Gly 3000 27 0 2 NIL NIL 2 LGT-Ta 2
14 VEDI 43 M YES NO NO 11 33 140 10.6 30 3 0.4 138 2 RL 15 1 Ped N NO RL 1 Ped Gly 2000 14 2 1 NIL NIL 2 LGT-Ta 0
15 PREMDASS 72 M NO NO YES 9.6 32 132 9.2 28 4 0.4 130 2 T 20 1 Ped N NO T 1 Ped Gly 3000 25 0 1.6 NIL NIL 2 LGT-T1 2
16 BARANABAS 54 M YES YES NO 12.1 38 140 11.5 34 4 0.6 134 6 LL 13 1 Ped N NO LL 1 Ped Gly 2000 22 0 1 NIL NIL 2 LGT-T1 1
17 DEVADASS 68 M YES YES NO 9.6 32 136 9.2 31 3 0.4 132 4 RL 35 1 Ped N NO RL 1 Ped Gly 3000 28 3 2.3 NIL YES 8 HGT-T1 2
18 MANOHARAN 58 M YES NO NO 10.2 34 144 9.8 32 2 0.4 140 4 LL, RL 12 2 Ped N NO
LL,
RL 2 Ped Gly 3000 25 0 1.2 NIL NIL 2 LGT-T1 2
19 PRAKASH 67 M NO YES NO 11.2 35 130 10.6 33 2 0.6 129 1 T 32 1 Ped N NO T 1 Ped Gly 3000 21 0 1.5 NIL NIL 2 LGT-Ta 2
20 VENDAR 56 M YES NO YES 9.6 24 140 9 23 1 0.6 136 4 D 26 1 Ped N NO D 1 Ped Gly 3000 23 0 1.4 NIL NIL 2 LGT-T1 1
21 KANNAN 70 M NO NO NO 9.8 27 140 9.6 25 2 0.2 138 2 LL 23 1 Ped N NO LL 1 Ped Gly 2000 24 0 1.5 NIL NIL 2 HGT-T1 2
22 PONNAR 66 M YES YES NO 10.2 32 138 10.1 30 2 0.1 136 2 LL 35 1 Ped N NO LL 1 Ped Gly 3500 34 2 2 NIL NIL 2 LGT-T1 2
23 MOOKIAH 65 M YES NO NO 10.4 34 134 10 31 3 0.4 132 2 LL 24 1 Ped N NO LL 1 Ped Gly 3000 23 0 1.5 NIL NIL 2 LGT-Ta 1
24 CHELLAMUTHU 62 M YES YES NO 9.8 28 140 9.6 26 2 0.2 139 1 LL 23 1 Ped N NO LL 1 Ped Gly 2000 21 0 1.5 NIL NIL 2 LGT-T1 1
25 SHANTHA 50 F YES NO NO 10.2 32 140 9.6 30 2 0.6 136 4 LL 13 1 Ped N NO LL 1 Ped Gly 2500 23 0 1 NIL NIL 2 HGT-T1 1
26 KATHIRVEL 67 M YES NO YES 10.4 32 136 10.2 29 3 0.2 132 4 D 14 1 Ped N NO D 1 Ped Gly 2800 25 0 1 NIL NIL 2 LGT-Ta 1
27 MD.SIDDIQUE 65 M YES YES YES 11.2 33 134 10.6 30 3 0.6 133 1 LL 26 1 Ped N YES LL 1 Ped Gly 2000 25 1 2 NIL NIL 2 LGT-T1 2
28 RAJENDRAN 56 M YES NO NO 10.4 32 132 9.8 30 2 0.6 130 2 T 13 1 SES N NO T 1 SES Gly 2000 26 0 1 NIL NIL 2 SCC 2
29 NARAYANAN 55 M YES NO YES 9.6 27 136 9.0 25 2 0.6 132 4 T 23 1 Ped N NO T 1 Ped Gly 2500 27 0 2 NIL NIL 2 HGT-T1 2
30 AMMANULLAH 51 M YES NO YES 9.8 23 134 9.6 22 1 0.2 130 4 D 24 1 Ped N NO D 1 Ped Gly 2000 20 0 1.3 NIL NIL 2 LGT-Ta 2
31 KARNAN 70 M NO NO NO 9.6 26 143 9.5 25 1 0.1 138 5 D, T, LL 15 3 Ped N NO  T, LL 3 Ped Gly 3000 35 0 3 NIL NIL 2 HGT-T1 2
32 NATARAJAN 45 M NO NO YES 10.6 31 132 10.4 28 3 0.4 130 2 T 23 1 SES N NO T 1 SES Gly 2500 23 0 1.8 NIL NIL 2 ADENO 2
33 PAVADAI 65 M YES NO YES 11 32 138 10.8 30 2 0.2 132 6 RL 14 1 Ped N NO RL 1 Ped Gly 2000 21 0 1.3 NIL NIL 2 LGT-T1 1
34 EKAMBARAM 62 M YES NO NO 12.2 34 134 11.8 32 2 0.4 132 2 T 12 1 Ped N NO T 1 Ped Gly 2000 22 0 1.5 NIL NIL 2 LGT-Ta 1
35 RAMASAMY 67 M YES NO NO 11 32 140 10.4 30 2 0.6 132 8 RL 22 1 Ped N NO RL 1 Ped Gly 2500 28 0 2 NIL NIL 7 HGT-T1 2
36 MUTHUVEDI 60 M YES NO YES 9.9 25 138 9.8 24 1 0.1 134 4 LL 13 1 Ped N NO LL 1 Ped Gly 2000 20 0 1.2 NIL NIL 2 HGT-T1 2
37 GOPAL 65 M YES YES NO 10.2 33 131 9.6 31 2 0.6 128 3 D 14 1 Ped N NO D 1 Ped Gly 2800 19 0 1 NIL NIL 2 LGT-Ta 1
38 MUNIYAMMAL 50 F NO NO NO 9.8 26 135 9.6 24 2 0.2 132 3 T 15 1 Ped N NO T 1 Ped Gly 2500 20 0 1 NIL NIL 2 LGT-Ta 1
39 DURAIRAJ 70 M YES YES NO 11.2 31 138 11 28 3 0.2 135 3 RL 21 1 Ped N NO RL 2 Ped Gly 2000 25 1 1.6 NIL NIL 2 LGT-T1 2
40 KRISHNAN 53 M YES NO NO 10.4 30 142 10 27 3 0.4 141 1 RL 22 1 Ped N NO RL 1 Ped Gly 2000 26 0 1.5 NIL NIL 2 LGT-T1 2
41 KUPPAN 60 M YES YES NO 9.6 28 134 9.2 26 2 0.4 133 1 LL 13 1 Ped N NO LL 1 Ped Gly 2000 22 0 2 NIL NIL 2 HGT-T1 1
42 MARY 65 F NO NO NO 10.4 29 134 10.2 25 4 0.2 133 1 T 14 1 Ped N NO T 1 Ped Gly 2000 23 0 1.5 NIL NIL 2 LGT-Ta 2
43 SIVAKUMAR 40 M NO NO YES 10.4 33 136 10 30 3 0.4 134 2 T 13 1 Ped N NO T 1 Ped Gly 2000 25 0 2 NIL NIL 2 LGT-T1 0
44 EZHUMALAI 47 M NO NO NO 9.6 31 134 9.4 28 3 0.2 132 2 T 12 1 Ped N NO T 1 Ped Gly 2500 25 0 1 NIL NIL 2 LGT-T1 0
45 RAMASAMY 65 M YES NO NO 9.5 32 133 9.4 30 2 0.1 131 2 LL 26 1 Ped N NO LL 1 Ped Gly 2500 32 2 1.4 NIL NIL 2 LGT-T1 2
46 JAYAMMAL 55 F NO YES NO 9.4 30 140 9.2 28 2 0.2 138 2 RL 16 1 Ped N NO RL 1 Ped Gly 2000 26 0 1.5 NIL NIL 2 HGT-T1 2
47 SOLAIPPAN 60 M YES NO YES 9.8 28 142 9.4 26 2 0.4 140 2 T 14 1 Ped N NO T 1 Ped Gly 2000 18 0 1 NIL NIL 2 LGT-Ta 2
48 ARUNAN 58 M YES NO NO 10.2 31 142 9.8 29 2 0.4 140 2 RL 32 1 SES N NO RL 1 SES Gly 3000 34 1 2 NIL NIL 3 HGT-T2 2
49 BOOTHALINGAM 72 M YES YES NO 11 32 138 10.8 30 2 0.2 136 2 LL 33 1 Ped N NO LL 1 Ped Gly 3200 32 1 1 NIL NIL 2 LGT-T1 1
50 KHADARBASHA 76 M YES NO YES 11 33 148 10.6 30 3 0.4 142 6 AW 24 1 Ped N NO AW 1 Ped Gly 3000 38 0 1.2 NIL NIL 2 HGT-T1 1
HTN HYPERTENSION LL LEFT LATERAL WALL
DM DIABETES RL RIGHT LATERAL WALL
Hb HEMOGLOBIN T TRIGONE
Na SODIUM D DOME
K POTASSIUM AW ANTERIOR WALL
HbD HEMOGLOBIN DEFICIT PW POSTERIOR WALL
NaD SODIUM DEFICIT PED PEDUNCULATED
L LOCATION SES SESSILE
S SIZE GLY GLYCINE
N NUMBER D DAY
M MORPHOLOGY HGT HIGH GRADE TUMOUR
UT UPPER TRACTS LGT LOW GRADE TUMOUR
LN LYMPH NODE SAL SALINE
IR IRRIGANT HPE HISTOPATHOLOGICAL EXAMINATION
RT RESECTION TIME PERF PERFORATION
OJ OBTURATOR JERK TAG THERMAL ARTEFACT GRADE
SW SPECIMEN WEIGHT TURS TUR SYNDROME
USG ULTRASONOGRAPHY CECT CONTRAST ENHANCED CT
TURBT TUR OF BLADDER TUMOURS CP CATHETERISATION PERIOD
PCV PACKED CELL VOLUME PCVD DIFFERENCE IN PCV
MASTER CHART-BIPOLAR
Pre-operative Post-operative CECT CYSTOSCOPY TURBT HPE
SL
No Name Age Sex Smoking HTN DM  Hb PCV Na  Hb PCV PCVD HbD Na NaD L S N M UT LN L N M IR IV(ml) RT(min) OJ SW TURS PERF CP HISTO TAG
1 RAMANATHAN 64 M YES NO YES 10.2 30 136 10 29 1 0.2 134 2 LL 20 1 PED N NO LL 1 PED SAL 2600 33 0 1.6 NIL NIL 2 LGT-Ta 1
2 VATSALA 59 F NO NO YES 9.8 27 144 9.4 26 1 0.4 140 4 RL 10 1 PED N NO RL 1 PED SAL 2800 30 0 1 NIL NIL 2 LGT-Ta 0
3 RAMANI 55 F NO NO YES 11.6 33 145 11.2 32 1 0.4 138 7 LL 20 1 SES N NO LL 1 SES SAL 2500 35 0 1.4 NIL NIL 2 SCC 1
4 EZHUMALAI 48 M NO NO NO 10.8 32 138 10.6 31 1 0.2 136 2 TRI 10 1 PED N NO T 1 PED SAL 2400 31 0 1 NIL NIL 2 LGT-Ta 1
5 KANNAN 66 M YES YES NO 9.5 27 135 9.2 26 1 0.3 132 3 LL 30 1 PED N NO LL 1 PED SAL 2200 30 0 3 NIL NIL 2 LGT-T1 1
6 NATARAJAN 63 M NO NO NO 10.3 30 138 10 28 2 0.3 136 2 RL 20 1 PED N NO RL 1 PED SAL 2300 33 0 1.3 NIL NIL 2 LGT-Ta 0
7 SAMUEL 61 M YES YES NO 9.7 28 137 9.6 26 2 0.1 136 1 RL 20 1 PED N NO RL 1 PED SAL 2500 32 0 1.2 NIL NIL 2 HGT-T1 1
8 SOUNDARAJAN 50 M YES YES NO 9.6 27 138 9.4 26 1 0.2 136 2 LL 10 1 PED N NO LL 1 PED SAL 2300 36 0 1 NIL NIL 2 LGT-Ta 0
9 MANIKANDAN 70 M NO NO NO 11 32 136 10.6 31 1 0.4 135 1 LL, D 10 2 PED N NO
LL,
D 2 PED SAL 2200 30 0 2.5 NIL NIL 2 LGT-Ta 2
10 SELVARAJ 53 M YES YES NO 11.2 33 138 10.6 32 1 0.6 132 6 LL 10 1 PED N NO LL 1 PED SAL 2700 34 0 1 NIL NIL 2 LGT-Ta 0
11 PALANIVEL 32 M YES NO NO 9.6 25 134 9.4 24 1 0.2 132 2 D 20 1 PED N NO D 1 PED SAL 2400 37 0 2 NIL NIL 2 LGT-Ta 0
12 FAROOK 40 M YES YES YES 11.2 32 143 10.4 31 1 0.8 138 5 RL 32 1 PED N NO RL 1 PED SAL 2500 40 0 2.8 NIL NIL 2 LGT-T1 2
13 PARVATHI 55 F NO NO YES 10.4 31 142 10.2 30 1 0.2 140 2 TRI 33 1 PED N NO T 1 PED SAL 2600 35 0 2 NIL NIL 3 LGT-T1 1
14 KALIAMOORHTY 57 M YES YES NO 9.4 27 138 9 25 2 0.4 136 2 D 12 1 SES N NO D 1 PED SAL 2300 32 0 1 NIL NIL 2 LGT-Ta 0
15 MURUGAN 65 M NO NO NO 11.2 34 152 10.6 33 1 0.6 148 4 RL 22 1 PED N NO RL 1 PED SAL 2500 34 0 2 NIL NIL 2 LGT-T1 2
16 MURUGESAN 45 M YES NO NO 9.6 28 144 9 27 1 0.6 142 2 TRI 13 1 PED N NO T 1 PED SAL 2200 36 0 1 NIL NIL 2 LGT-Ta 0
17 GANESAN 45 M NO NO NO 12 36 138 11.5 34 2 0.5 136 2 LL 20 1 PED N NO PW 1 PED SAL 2300 32 0 1.5 NIL NIL 2 LGT-Ta 1
18 GOVINDARAJ 55 M YES NO NO 9.8 25 138 9.2 24 1 0.6 136 2 LL 22 1 PED N NO LL 1 PED SAL 2200 30 1 2 NIL NIL 2 HGT-T1 0
19 ZEENATH 55 F NO YES NO 10.2 32 144 10 31 1 0.2 142 2 LL 13 1 PED N NO LL 1 PED SAL 2800 32 0 1 NIL NIL 2 LGT-Ta 0
20 SIVAGAMI 52 F NO YES NO 11 33 138 10.2 32 1 0.8 136 2
LL,
RL 23 1 PED N NO
LL,
RL 1 PED SAL 1900 30 1 2.5 NIL NIL 2 HGT-T1 1
21 GOPAL 70 M YES NO YES 9.8 27 143 9.2 26 1 0.6 142 1 LL 24 1 PED N NO LL 1 PED SAL 2200 31 0 2.5 NIL NIL 2 LGT-T1 0
22 NATARAJAN 45 M YES NO NO 10.2 31 152 9.8 30 1 0.4 145 7 LL 25 1 PED N NO LL 1 PED SAL 2300 35 0 2.6 NIL NIL 2 LGT-T1 2
23 RAMAN 55 M YES YES NO 9.6 25 138 9.5 24 1 0.1 132 6 RL 15 1 PED N NO AW 1 Ped SAL 2000 30 0 2 NIL NIL 2 LGT-Ta 1
24 KASIPILLAI 70 M YES YES NO 10.8 32 138 10.2 31 1 0.6 136 2 RL 12 2 PED N NO RL 2 PED SAL 1700 32 0 1.3 NIL NIL 2 HGT-T1 0
25 HARIDOSS 55 M YES NO YES 9.6 28 132 9.5 27 1 0.1 128 4 RL 22 1 PED N NO AW 1 PED SAL 2100 35 0 2.4 NIL NIL 2 LGT-T1 0
26 RAHAMATULLA 74 M YES YES NO 9.6 28 144 9.2 26 2 0.4 140 4 RL 33 1 PED N NO RL 1 PED SAL 1500 32 0 2.6 NIL NIL 2 LGT-T1 0
27 CHELLAPPAN 76 M YES YES NO 10.2 32 140 9.6 30 1 0.6 136 4 RL 34 1 PED N NO RL 1 PED SAL 1600 38 1 3 NIL NIL 2 HGT-T1 1
28 PALANIVEL 55 M YES NO NO 9.6 27 132 9.4 26 1 0.2 130 2 LL 22 1 PED N NO LL 1 PED SAL 2000 35 0 2 NIL NIL 2 HGT-T1 0
29 MURUGAN 46 M YES YES NO 10.2 31 142 9.8 28 3 0.4 138 4 LL 21 1 PED N NO LL 1 PED SAL 1800 32 0 1.7 NIL NIL 2 LGT-Ta 0
30 RAVANAN 36 M YES NO YES 9.5 24 142 9.4 23 1 0.1 140 2 LL 23 1 PED N NO LL 1 PED SAL 1900 35 0 2 NIL NIL 2 LGT-T1 2
31 MD.IMTIAZ 70 M YES YES YES 9.8 25 134 9.6 24 1 0.2 130 4 T,D 12 2 PED N NO T,D 2 PED SAL 2000 32 0 1 NIL NIL 2 LGT-Ta 1
32 PALAMALAI 56 M NO NO NO 9.8 26 132 9.2 24 2 0.6 130 2 T 28 1 PED N NO T 1 PED SAL 2100 34 0 1.5 NIL NIL 2 LGT-T1 0
33 MADURAI 39 M YES NO NO 9.4 24 138 9 23 1 0.4 132 6 RL 17 1 PED N NO RL 1 PED SAL 2200 31 0 1 NIL NIL 2 LGT-Ta 0
34 PALANI 53 M YES NO YES 10.2 32 138 9.8 31 1 0.4 132 6 RL 32 1 PED N NO RL 1 PED SAL 1800 38 0 1.5 NIL NIL 4 LGT-T1 0
35 PONNAIAN 70 M YES NO NO 9.8 25 134 9.6 24 1 0.2 132 2 T 16 1 PED N NO PW 1 PED SAL 2000 35 0 1 NIL NIL 2 LGT-Ta 0
36 CHINNAPPAN 63 M YES YES NO 9.6 28 132 9 27 1 0.6 131 1 LL 29 1 SES N NO LL 1 SES SAL 1700 34 0 1.4 NIL NIL 2 HGT-T1 1
37 SENGAN 66 M YES NO NO 11 33 134 10.6 31 2 0.4 130 4 LL 23 1 PED N NO LL 1 PED SAL 2000 35 1 1.5 NIL NIL 2 LGT-T1 0
38 PERIYAVAN 58 M YES YES YES 11 33 132 10.6 32 1 0.4 130 2 D 13 1 PED N NO T 1 PED SAL 2000 36 0 1 NIL NIL 2 LGT-Ta 0
39 CHELLAMA 58 F NO NO NO 9.8 28 138 9.2 27 1 0.6 136 2 T 25 1 PED N NO T 1 PED SAL 1900 35 0 1.6 NIL NIL 2 LGT-Ta 0
40 NAGARAJAN 48 M NO NO NO 9.6 27 132 9.4 26 1 0.2 130 2 RL 35 1 SES N NO RL 1 SES SAL 2000 32 0 2 NIL NIL 3 HGT-T1 1
41 GOVINDASAMY 67 M YES NO YES 9.4 26 136 9.2 25 1 0.2 132 4 LL 28 1 PED N NO LL 1 PED SAL 2200 34 0 1.8 NIL NIL 2 LGT-T1 0
42 DURAI 58 M YES NO YES 9.8 25 140 9.6 24 1 0.2 136 4 RL 32 1 SES N NO RL 1 SES SAL 1800 35 0 2 NIL NIL 2 HFT-T2 1
43 GANESA NADAR 63 M YES YES NO 11 32 134 10.8 31 1 0.2 132 2 T 14 2 PED N NO T 2 PED SAL 2200 36 0 1.1 NIL NIL 2 LGT-Ta 0
44 MATHEW 80 M YES NO NO 9.6 26 132 9.4 24 2 0.2 130 2 LL 35 1 PED N NO LL 1 PED SAL 2000 35 0 2.3 NIL NIL 2 LGT-T1 1
45 KRISHNIAH 56 M NO NO YES 9.6 27 128 9.2 26 1 0.4 126 2 LL 26 1 PED N NO LL 1 PED SAL 2000 32 0 1.5 NIL NIL 2 LGT-T1 0
46 MARKADEYAN 51 M YES NO NO 9.8 28 138 9.6 27 1 0.2 132 6 D 23 1 PED N NO T 1 PED SAL 1800 35 0 1.4 NIL NIL 3 LGT-Ta 0
47 PEETHAMBARAM 54 M YES YES NO 10.2 32 134 9.4 31 1 0.8 133 1 RL 25 1 SES N NO RL 1 SES SAL 2000 35 0 1.2 NIL NIL 2 LGT-T1 1
48 MARUTHU 67 M YES NO YES 9.6 27 138 9.2 25 2 0.4 136 2 LL 32 1 SES N NO LL 1 SES SAL 2000 36 0 2.4 NIL NIL 2 HGT-T2 0
49 MARIAMMA 60 F YES NO NO 9.8 27 138 9.4 26 1 0.4 134 4 LL 15 1 PED N NO PW 1 PED SAL 1500 34 0 1 NIL NIL 2 LGT-Ta 1
50 MOHAN 66 M NO NO NO 9.4 26 138 9.2 25 1 0.2 136 2 T 23 1 PED N NO T 1 PED SAL 2500 35 0 1.5 NIL NIL 2 LGT-Ta 0
HTN HYPERTENSION LL LEFT LATERAL WALL
DM DIABETES RL RIGHT LATERAL WALL
Hb HEMOGLOBIN T TRIGONE
Na SODIUM D DOME
K POTASSIUM AW ANTERIOR WALL
HbD HEMOGLOBIN DEFICIT PW POSTERIOR WALL
NaD SODIUM DEFICIT PED PEDUNCULATED
L LOCATION SES SESSILE
S SIZE IN MM GLY GLYCINE
N NUMBER D DAY
M MORPHOLOGY HGT HIGH GRADE TUMOUR
UT UPPER TRACTS LGT LOW GRADE TUMOUR
LN LYMPH NODE SAL SALINE
IR IRRIGANT HPE HISTOPATHOLOGICAL EXAMINATION
RT RESECTION TIME PERF PERFORATION
OJ OBTURATOR JERK TAG THERMAL ARTEFACT GRADE
SW SPECIMEN WEIGHT IN GRAMS TURS TUR SYNDROME
USG ULTRASONOGRAPHY CECT CONTRAST ENHANCED CT
TURBT TUR OF BLADDER TUMOURS CP CATHETERISATION PERIOD
PCV PACKED CELL VOLUME PCVD DIFFERENCE IN PCV
APPENDIX-6
TURNITIN ORIGINALITY REPORT

